Zota Health Care LImited - Asset Resilience Ratio
Zota Health Care LImited (ZOTA) has an Asset Resilience Ratio of 0.68% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ZOTA current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Zota Health Care LImited's Asset Resilience Ratio has changed over time. See what is Zota Health Care LImited's book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Zota Health Care LImited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Zota Health Care LImited.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs14.87 Million | 0.34% |
| Short-term Investments | Rs14.87 Million | 0.34% |
| Total Liquid Assets | Rs29.74 Million | 0.68% |
Asset Resilience Insights
- Limited Liquidity: Zota Health Care LImited maintains only 0.68% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Zota Health Care LImited Industry Peers by Asset Resilience Ratio
Compare Zota Health Care LImited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO |
Biotechnology | 11.59% |
|
Summit Therapeutics PLC
NASDAQ:SMMT |
Biotechnology | 0.00% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 0.05% |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
Biotechnology | 0.58% |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
Biotechnology | 8.08% |
|
BrightGene Bio Medical Technology C
SHG:688166 |
Biotechnology | 1.00% |
|
BioArctic AB (publ)
ST:BIOA-B |
Biotechnology | 72.35% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
Annual Asset Resilience Ratio for Zota Health Care LImited (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Zota Health Care LImited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.68% | Rs29.74 Million ≈ $321.63K |
Rs4.39 Billion ≈ $47.49 Million |
+0.39pp |
| 2024-03-31 | 0.29% | Rs6.56 Million ≈ $70.94K |
Rs2.28 Billion ≈ $24.69 Million |
-1.01pp |
| 2023-03-31 | 1.29% | Rs20.46 Million ≈ $221.29K |
Rs1.58 Billion ≈ $17.10 Million |
-1.96pp |
| 2022-03-31 | 3.25% | Rs45.22 Million ≈ $489.02K |
Rs1.39 Billion ≈ $15.04 Million |
+0.16pp |
| 2021-03-31 | 3.09% | Rs26.39 Million ≈ $285.35K |
Rs854.69 Million ≈ $9.24 Million |
+1.26pp |
| 2020-03-31 | 1.83% | Rs16.21 Million ≈ $175.29K |
Rs884.79 Million ≈ $9.57 Million |
+1.83pp |
| 2019-03-31 | 0.00% | Rs120.00 ≈ $1.30 |
Rs896.07 Million ≈ $9.69 Million |
+0.22pp |
| 2018-03-31 | -0.22% | Rs-2.00 Million ≈ $-21.63K |
Rs917.94 Million ≈ $9.93 Million |
+0.03pp |
| 2016-03-31 | -0.24% | Rs-1.08 Million ≈ $-11.63K |
Rs440.52 Million ≈ $4.76 Million |
-- |
About Zota Health Care LImited
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores u… Read more